OP03 Mapping the observable IBDverse: Using massive-scale single-cell RNA sequencing of gut and blood samples to nominate genes, cell types and pathways driving IBD susceptibility
Barbara Harris(George Washington University), Carl A. Anderson(Wellcome Sanger Institute), Michelle Strickland(Wellcome Sanger Institute), Laura Fachal(University of Cambridge), Mennatallah Ghouraba(Queen Mary University of London), Matiss Ozols(Manchester Academic Health Science Centre), Min Hu(China Agricultural University), Monika Krzak(Wellcome Sanger Institute), Tim Raine(National Health Service), Rebecca E. McIntyre(Wellcome Sanger Institute), Noor Wana(Wellcome Sanger Institute), Jasmin Ostermayer(Wellcome Sanger Institute), L Ramirez-Navaro(Wellcome Sanger Institute), Tobi Alegbe(Wellcome Sanger Institute), Marcus Tutert, Gareth‐Rhys Jones(MRC Centre for Regenerative Medicine)
Cited by 2
Related Papers
A map of human genome variation from population-scale sequencing
|Nature|2010|8.1k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
A reference panel of 64,976 haplotypes for genotype imputation
|Nature Genetics|2016|3.3k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k